{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:40:22Z","timestamp":1787755222840,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Biotech Vision Care Pvt. Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40123-026-01456-4","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T18:26:51Z","timestamp":1784485611000},"page":"3041-3054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Clinical Outcomes of a 1.0% Versus 1.4% Sodium Hyaluronate OVD in Cataract Surgery: A Prospective Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Shreyas","family":"Ramamurthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandapani","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavnita","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2176-5824","authenticated-orcid":false,"given":"Bhargav","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"issue":"4","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s40123-021-00403-9","volume":"10","author":"AF Borkenstein","year":"2021","unstructured":"Borkenstein AF, Borkenstein EM, Malyugin B. Ophthalmic viscosurgical devices (OVDs) in challenging cases: a review. Ophthalmol Ther. 2021;10(4):831\u201343. https:\/\/doi.org\/10.1007\/s40123-021-00403-9.","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jcrs.2014.04.025","volume":"40","author":"FTA Kretz","year":"2014","unstructured":"Kretz FTA, Limberger IJ, Auffarth GU. Corneal endothelial cell coating during phacoemulsification using a new dispersive hyaluronic acid ophthalmic viscosurgical device. J Cataract Refract Surg. 2014;40(11):1879\u201384. https:\/\/doi.org\/10.1016\/j.jcrs.2014.04.025.","journal-title":"J Cataract Refract Surg"},{"key":"1456_CR3","unstructured":"FDA. Premarket approval (PMA). https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?ID=P810031. Accessed 2025 Oct 30."},{"key":"1456_CR4","unstructured":"ISO 11979-10:2018\u2014Ophthalmic implants\u2014intraocular lenses\u2014Part 10: clinical investigations of intraocular lenses for correction of ametropia in phakic eyes. https:\/\/www.iso.org\/standard\/69036.html. Accessed 2025 Oct 30."},{"issue":"2","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/08820538.2013.833261","volume":"30","author":"S Kugu","year":"2015","unstructured":"Kugu S, Erdogan G, Sahin Sevim M, Ozerturk Y. A clinical comparison of safety and efficacy in phacoemulsification with versus without ophthalmic viscoelastic device. Semin Ophthalmol. 2015;30(2):96\u2013100. https:\/\/doi.org\/10.3109\/08820538.2013.833261.","journal-title":"Semin Ophthalmol"},{"issue":"9","key":"1456_CR6","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/s0886-3350(02)01540-7","volume":"28","author":"K Miyata","year":"2002","unstructured":"Miyata K, Maruoka S, Nakahara M, et al. Corneal endothelial cell protection during phacoemulsification: low- versus high-molecular-weight sodium hyaluronate. J Cataract Refract Surg. 2002;28(9):1557\u201360. https:\/\/doi.org\/10.1016\/s0886-3350(02)01540-7.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0420.2006.00784.x","volume":"85","author":"A Storr-Paulsen","year":"2007","unstructured":"Storr-Paulsen A, N\u00f8rregaard JC, Farik G, T\u00e5rnh\u00f8j J. The influence of viscoelastic substances on the corneal endothelial cell population during cataract surgery: a prospective study of cohesive and dispersive viscoelastics. Acta Ophthalmol Scand. 2007;85(2):183\u20137. https:\/\/doi.org\/10.1111\/j.1600-0420.2006.00784.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"1456_CR8","unstructured":"VSY Biotechnology. PROTECTALON. https:\/\/www.vsybiotechnology.com\/documents\/pdf\/9-protectalonrev09-2.pdf. Accessed 2025 Nov 7."},{"key":"1456_CR9","unstructured":"Bio-Tech Vision Care. Sodium hyaluronate ophthalmic solutions. https:\/\/eifu.biotechhealthcare.com\/assets\/uploads\/siteDocument\/1663065825_ca1d0ba1086368f47c42.pdf. Accessed 2025 Nov 7."},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/OPTH.S137712","volume":"11","author":"WK Lim","year":"2017","unstructured":"Lim WK, Soh ZD, Choi HKY, Theng JTS. Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin Ophthalmol. 2017;11:1205\u201311. https:\/\/doi.org\/10.2147\/OPTH.S137712.","journal-title":"Clin Ophthalmol"},{"key":"1456_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(01)00429-4","author":"A Miyata","year":"2001","unstructured":"Miyata A. Clinical and experimental observation of glistening in acrylic intraocular lenses. Jpn J Ophthalmol. 2001. https:\/\/doi.org\/10.1016\/S0021-5155(01)00429-4.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"1456_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/jop.2024.0044","volume":"40","author":"C Pagnacco","year":"2024","unstructured":"Pagnacco C, Tosi R, Dalsaso J, Fraccaroli S, Saggin F, Marchini G. A prospective, randomized, controlled clinical investigation comparing the efficacy and safety of sodium hyaluronate-based ophthalmical viscosurgical devices FIDIAL PLUS and IAL\u00ae-F in cataract surgery. J Ocul Pharmacol Ther. 2024;40(8):469\u201376. https:\/\/doi.org\/10.1089\/jop.2024.0044.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2020","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"8874850","DOI":"10.1155\/2020\/8874850","volume":"18","author":"L Daas","year":"2020","unstructured":"Daas L, Larrosa JM, Gavin A, et al. Clinical comparison of the performance of two marketed ophthalmic viscoelastic devices (OVDs): the bacterially derived Healon PRO OVD and animal-derived Healon OVD. J Ophthalmol. 2020;18(2020):8874850. https:\/\/doi.org\/10.1155\/2020\/8874850.","journal-title":"J Ophthalmol"},{"issue":"8","key":"1456_CR15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/j.jcrs.0000000000001201","volume":"49","author":"M Packer","year":"2023","unstructured":"Packer M, Shultz M, Loden J, Lau G. Safety and effectiveness comparison of a new cohesive ophthalmic viscosurgical device. J Cataract Refract Surg. 2023;49(8):804\u201311. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001201.","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1097\/j.jcrs.0000000000000904","volume":"48","author":"M Packer","year":"2022","unstructured":"Packer M, Berdahl JP, Goldberg DF, Hosten L, Lau G. Safety and effectiveness of a new ophthalmic viscosurgical device: randomized, controlled study. J Cataract Refract Surg. 2022;48(9):1050\u20136. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000904.","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/j.jcrs.0000000000001473","volume":"50","author":"L De Rosa","year":"2024","unstructured":"De Rosa L, Furiosi L, Pellegrini M, Yu AC, Scorcia V, Busin M. Prospective randomized clinical trial evaluating efficacy and safety of a new ophthalmic viscosurgical device in patients undergoing cataract surgery. J Cataract Refract Surg. 2024;50(9):906\u201311. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001473.","journal-title":"J Cataract Refract Surg"},{"key":"1456_CR18","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2019.09609","author":"B Acar","year":"2019","unstructured":"Acar B. The outcomes of a dispersive ophthalmic viscosurgical device. Beyoglu Eye J. 2019. https:\/\/doi.org\/10.14744\/bej.2019.09609.","journal-title":"Beyoglu Eye J"},{"issue":"1","key":"1456_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2019-000280","volume":"4","author":"G Monaco","year":"2019","unstructured":"Monaco G, Gari M, Pelizzari S, et al. New ophthalmic dual-viscoelastic device in cataract surgery: a comparative study. BMJ Open Ophthalmol. 2019;4(1):e000280. https:\/\/doi.org\/10.1136\/bmjophth-2019-000280.","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"1456_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jcrs.2016.10.025","volume":"43","author":"GU Auffarth","year":"2017","unstructured":"Auffarth GU, Auerbach FN, Rabsilber T, et al. Comparison of the performance and safety of 2 ophthalmic viscosurgical devices in cataract surgery. J Cataract Refract Surg. 2017;43(1):87\u201394. https:\/\/doi.org\/10.1016\/j.jcrs.2016.10.025.","journal-title":"J Cataract Refract Surg"},{"key":"1456_CR21","first-page":"281","volume":"13","author":"I Shatriah","year":"1994","unstructured":"Shatriah I, Liza-Sharmini AT, Mohtar I, Zulkifli AG, Nik-Azlan Z. Effect of Healon\u00a05 and Healon GV on corneal endothelial morphology after phacoemulsification surgery. Int Med J. 1994;13:281\u20135.","journal-title":"Int Med J"},{"issue":"12","key":"1456_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.jcrs.2019.08.007","volume":"45","author":"DH Chang","year":"2019","unstructured":"Chang DH, Christie WC, Loden JC, Smith PJ, Jackson BE. Clinical evaluation of a bacterially derived sodium hyaluronate 2.3% ophthalmic viscosurgical device. J Cataract Refract Surg. 2019;45(12):1789\u201396. https:\/\/doi.org\/10.1016\/j.jcrs.2019.08.007.","journal-title":"J Cataract Refract Surg"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01456-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01456-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:39:37Z","timestamp":1787751577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01456-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01456-4","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bhargav Joshi and Bhavnita Soni are salaried employees of Biotech Vision Care Pvt. Ltd., India. Shreyas Ramamurthy and Dandapani Ramamurthy declared no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of Eye Foundation, Coimbatore, Tamil Nadu, India, prior to initiation. Written informed consent was obtained from all participants after providing a detailed explanation of the study protocol before the initiation of the study. The study was conducted in accordance with the Declaration of Helsinki, ISO 14155:2020, and ISO 15798:2022. It was registered under the clinical trial registry of India with CTRI\/2023\/03\/050365.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}